Project Grant T32AI200899
Award Date 8/6/26
Completion Date 7/31/31
Dollars Obligated $505K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $201,600 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an Immunology Training Program. The program establishes a collaboration across three Houston-area institutions—Baylor College of Medicine, University of Texas Health Science Center at Houston, and MD Anderson Cancer Center—to train predoctoral immunology researchers. Four carefully selected...
- The National Institute of Allergy and Infectious Diseases, a division of the Department of Health and Human Services, awarded the University of Maryland, Baltimore $312,537 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 1, 2026, to support the Mechanisms Integrating Nervous and Immune Systems Training Program (MINISTP). The award funds a two-tiered training curriculum designed to prepare three graduate students and two post-doctoral researchers for up to...
- The National Institute of Allergy and Infectious Diseases awarded The Regents of the University of California, San Francisco $201,744 on June 4, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support a five-year research and training project investigating the distinct roles of NR4A1 and NR4A3 transcription factors in thymic T cell tolerance. The research aims to understand how NR4A transcription factors—whose expression scales with self-reactivity—translate T...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $452,128 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research training in infection and immunity. The award funds the Baylor College of Medicine Research Training in Infection and Immunity program, which will train four MD, MD/PhD, or PhD postdoctoral fellows annually for two years of mentored research training. The program provides a...
- The National Institute of Allergy and Infectious Diseases awarded The Regents of the University of California, San Francisco $666,065 on June 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the molecular basis for immunogenic B cell responses to virus-like antigen display. The research leverages a modular platform of liposomes decorated with model antigens to independently control epitope affinity and density. The work aims to identify proximal...
- The National Institute of Allergy and Infectious Diseases awarded The Regents of the University of California, San Francisco $182,196 on June 4, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop antibody-driven bioconjugation methods that chemically modify primary immune cells and disease-associated proteins to redirect cytotoxicity toward diseased cells as an alternative to genetic engineering approaches. The award funds synthesis and characterization...
- The National Institute of Allergy and Infectious Diseases awarded $201,744 to The Regents of the University of California, San Francisco on April 15, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to fund research into transcriptional mechanisms that drive dysregulated type 17 mucosal inflammation via innate lymphoid cells. The project investigates how group 3 innate lymphoid cells (ILC3s) trigger and sustain aberrant type 17 immune responses in chronic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego a $3.19 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 16, 2025, with a completion date of June 30, 2029. This grant funds investigator-initiated biomedical research examining the roles and regulation of tissue-resident CD8 T cells during persistent viral infection, utilizing the lymphocytic...
- The National Institute of Allergy and Infectious Diseases awarded The Regents of the University of California, San Francisco $813,236 on August 17, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to elucidate cell signaling determinants of human regulatory T cell (Treg) persistence. The research investigates mechanisms controlling Treg survival and function, focusing on improved persistence as a barrier to therapeutic efficacy in Treg cell therapies for autoimmune,...
- The National Institute of Allergy and Infectious Diseases awarded The Regents of the University of California, San Francisco $874,531 on May 11, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to model dynamic CD8+ T cell–virus interactions in post-treatment control of HIV. The project comprehensively defines mechanistic features of CD8+ T cell responses that most strongly relate to control of HIV after stopping antiretroviral therapy. Research will examine...